🧬 This Taiwanese biotech startup is taking on one of medicine’s toughest challenges: fibrosis.
With a groundbreaking nucleic acid therapy aimed at reversing lung scarring in diseases like IPF, they’re not just slowing damage — they’re targeting the root cause.
🔬 Read how this team could change the future of pulmonary care:
#Biotech #Fibrosis #IPF #RNAtherapy #TaiwanStartups #Healthtech #Sparknify
